Ramachandran Niro Ph.D 4
4 · Akoya Biosciences, Inc. · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-03-23$1.70/sh−2,310$3,927→ 287,210 total
Footnotes (1)
- [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on March 23, 2022, which vests in four (4) annual equal installments beginning on March 23, 2023 and annually thereafter until fully vested.